Artemis Capital Partners to acquire BioDot.

Artemis Capital Partners, a Boston-based private equity firm, agreed to acquire BioDot, a manufacturer of low volume precision and dispensing equipment. Financial terms were not disclosed. "This is an exciting time for our Company and we are thrilled to partner with Artemis. With the combined innovation of BioDot and the strategic ownership of Artemis, we will make a profound difference for our customers by continuing to deliver new high-demand technology-driven solutions globally with the quality and service that they can continue to rely upon," Anthony Lemmo, BioDot Chief Executive Officer.